Safety and Tolerability Trial of Psilocybin in Healthy Older Adults
NCT07516405
This study is recruiting at 6 US sites in 6 states, according to its ClinicalTrials.gov record last updated .
Summary
This study plans to learn more about the safety and tolerability of psychedelic administration (psilocybin) in healthy older adults ages 65-85.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Healthy Volunteer
- Older Adults (65-85 Years)
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1
- Ages
- 65 to 85 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- University of Colorado, Denver
- Last updated on ClinicalTrials.gov
- September 16, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- University of California San Francisco (UCSF) Department of Neurology · San Francisco, CA
Colorado · 1
- University of Colorado Anschutz Medical Campus · Aurora, CO
Georgia · 1
- Emory University Brain Health Center · Atlanta, GA
Massachusetts · 1
- Dana-Farber Cancer Institute · Boston, MA
Nebraska · 1
- University of Nebraska Medical Center · Omaha, NE
New York · 1
- New York University Langone Health, Center for Psychedelic Medicine · New York, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.